Your browser doesn't support javascript.
loading
Design and testing of a mobile health application rating tool.
Levine, David M; Co, Zoe; Newmark, Lisa P; Groisser, Alissa R; Holmgren, A Jay; Haas, Jennifer S; Bates, David W.
Afiliación
  • Levine DM; Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA USA.
  • Co Z; Harvard Medical School, Boston, MA USA.
  • Newmark LP; Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA USA.
  • Groisser AR; Department of Clinical Quality and Analysis, Partners Healthcare System, Somerville, MA USA.
  • Holmgren AJ; Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA USA.
  • Haas JS; Harvard Business School, Boston, MA USA.
  • Bates DW; Harvard Medical School, Boston, MA USA.
NPJ Digit Med ; 3: 74, 2020.
Article en En | MEDLINE | ID: mdl-32509971
Mobile health applications ("apps") have rapidly proliferated, yet their ability to improve outcomes for patients remains unclear. A validated tool that addresses apps' potentially important dimensions has not been available to patients and clinicians. The objective of this study was to develop and preliminarily assess a usable, valid, and open-source rating tool to objectively measure the risks and benefits of health apps. We accomplished this by using a Delphi process, where we constructed an app rating tool called THESIS that could promote informed app selection. We used a systematic process to select chronic disease apps with ≥4 stars and <4-stars and then rated them with THESIS to examine the tool's interrater reliability and internal consistency. We rated 211 apps, finding they performed fair overall (3.02 out of 5 [95% CI, 2.96-3.09]), but especially poorly for privacy/security (2.21 out of 5 [95% CI, 2.11-2.32]), interoperability (1.75 [95% CI, 1.59-1.91]), and availability in multiple languages (1.43 out of 5 [95% CI, 1.30-1.56]). Ratings using THESIS had fair interrater reliability (κ = 0.3-0.6) and excellent scale reliability (ɑ = 0.85). Correlation with traditional star ratings was low (r = 0.24), suggesting THESIS captures issues beyond general user acceptance. Preliminary testing of THESIS suggests apps that serve patients with chronic disease could perform much better, particularly in privacy/security and interoperability. THESIS warrants further testing and may guide software and policymakers to further improve app performance, so apps can more consistently improve patient outcomes.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Digit Med Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Digit Med Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido